| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |